Immunocore Holdings plc - American Depositary Shares — 四半期キャッシュフロー (NASDAQ:IMCR)

Financials

総資産 1.01 B1.03 B1.08 B1.1 B1.07 B 負債合計 648.79 M649.53 M693.91 M705.94 M686.24 M 純資産合計 360.72 M378.48 M388.48 M396.56 M381.03 M 負債および純資産合計 1.01 B1.03 B1.08 B1.1 B1.07 B 有利子負債合計 391.01 M391.53 M392.06 M392.59 M393.13 M 純負債 -429.36 M-445.5 M-490.75 M-499.77 M-471.03 M

Immunocore Holdings plc - American Depositary Shares

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

IMCR

Financials

Immunocore Holdings plc - American Depositary Shares

ニュース

Ideaya Biosciences Surges On Promising Results For Hard-To-Treat Melanoma

Jefferies、収益懸念でImmunocore株の格付けを引き下げ

Jefferies downgrades Immunocore stock rating on revenue concerns

Immunocore、Leerinkカンファレンスで戦略的成長とイノベーションを発表

Immunocore at Leerink Conference: Strategic Growth and Innovation

Immunocore Holdings plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IMCR) 2026-02-25

Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript

【決算速報】イミューノコアホールディングス、売上高は予想を下回り、利益は予想を下回る結果に

Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates

JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up

Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y